CD163 and melanoma: These macrophage–tumor cell hybrids express M2-like macrophage markers (CD163, CD204, and CD206) and epithelial markers (cytokeratins and EpCAM) and are found in the peripheral blood of patients with PDAC, melanoma, and breast, ovarian, and colorectal cancer [200, 204].